England & Company’s Post

Breaking News in Orthopedics: Henry Schein has entered the field of extremities and is now a new strategic buyer. England & Company was a part of it, in representing Extremity Medical in a strategic relationship with Schein.    We also conducted growth and working capital financings for Extremity this year. The England team completed four orthopedic transactions in 2023 and tops the global rankings in investment banking for orthopedic companies.   #orthopedics #extremities #orthopedicextremities #medicaldevice

📢 BREAKING NEWS 📢 - ZimVie Spine is no more! Major Shift in the Medical Device Landscape! ZimVie has officially announced its decision to divest its spine business, heralding a new era as a pure-play dental firm. With the agreement to sell this division to H.I.G. Capital for $375 million, ZimVie is carving out a future with a laser focus on the dental sector. 📈Shares of ZimVie (Nasdaq: ZIMV) witnessed a substantial surge by 23% following the announcement of this transformative deal. 💼 For my connections within ZimVie’s spine division, this transition opens a new chapter. As change is the only constant, I want to extend a hand to those affected by this shift and will point you in the right direction where possible. Read more below: https://lnkd.in/e56Zfn44 https://lnkd.in/ecmkWcMn #ZimVie #HIGCapital #HealthcareInnovation #MedicalDevices #AvetixGroup

Loci Orthopaedics Raises €12.8 million (13.9M) to Advance Novel Orthopaedic System to Market A medical device startup developing novel technologies to solve unresolved challenges in orthopaedic care, Loci Orthopaedics has secured €12.8 million ($13.9 million) in an oversubscribed Series A round. As announced by the company, the latest capital will be used to augment its initial clinical investigation for regulatory approval and advance its InDx Implant System to clinical validation and commercialization. Co-founded in 2017 by Dr. Brendan Boland and Gerry Clarke, the company received significant investments in its initial funding rounds. The latest round was spearheaded by Seroba, with support from other investors, including Johnson & Johnson Innovation JJDC Inc, Inc., and the European Innovation Council applicant support. Read more: https://lnkd.in/gkxGT8_8 #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #MedicalDevice #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

It’s #MSKMonday and I am here to talk about the public ortho markets. DePuy Synthes, as part of Johnson & Johnson MedTech was one of the first to kick-off Q2 earnings reporting season which will see many of its peers reading out in the coming several weeks, some as late as early August. DePuy reported 2.1% sales growth relative to Q2 of last year, and 3.2% compared to the prior period. https://lnkd.in/e5NbXxDM  On the one hand – we are likely through the post-covid bolus and the massive growth rates we have seen over the last several years will likely subside. On the other hand, some of DePuy’s closest peers, have been posting high single digit, and some (we won’t name names but we all know who) even hitting double digit growth. So in the coming weeks – where these peers land will show whether the whole market is cooling off equally, or whether we are continuing to see share shifts in a historical oligopoly market. Zimmer Biomet Stryker Smith+Nephew Enovis What will we see in the spine market where mergers have re-shaped the field? Where profitability has been impossible to come by as distributors continue to wield outsize power in access to surgeons? Globus Medical Alphatec Spine SeaSpine Medtronic Will big bets like Globus Medical’s Excelsius approval in TKA and its new knee system pay off by making a dent? https://lnkd.in/eyvuSdg5 Keep your eyes and ears peeled…

Learn about how Ortho-tag’s nanosensors can enhance pH monitoring around orthopaedic implants to reduce the incidence of Periprosthetic Joint Infection (PJI). This article explains how harnessing the power of this breakthrough technology will advance diagnostics, improve patient outcomes, and reduce healthcare costs. Join us on our journey at www.orthotag.com or contact us at info@orthotag.com to learn more about our system and how to invest. #pHsensing #healthcare  #medicaldevice#earlydetection #diseasemanagement #startup #venturecapital #funding#investors

M&As (+divestures), and subsequent integrations, transfers, harmonization, etc are all, necessary, part of the industry and innovation, yet also a lot of (thank-less) work for people involved. With that said....if you ever been part of M&A, you know it is exciting, challenging, and growing experience. Hence, I am excited to read that "Orthopedic M&A Activity Beginning to Bounce Back ❕ " ➡ Orthopedic M&A deals accelerated in 2023, according to ORTHOWORLD Inc. reporting. The jump in activity marks the first year-over-year increase since 2020... Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions: >> Smith+Nephew acquired CartiHeal last November to capture the company’s novel technology for regenerating cartilage in the knee. >> Enovis acquired LimaCorporate in January to gain addition tractions in the extremities and reconstruction segments. >> Stryker acquired France-based SERF in December to add to its hip replacement portfolio across Europe. >> Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it completed its merger with NuVasive last September. >> restor3d acquired @Conformis last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices. Looking forward seeing what 2024 will deliver! #mergersandacquisitions | #integrations

Healthcare practices may struggle to get the financing they need. Private credit alternatives are very favorable in todays financing environment. Consider working with us to review strategic alternatives including private credit. #privatecredit #healthcarecapitalmarkets #orthopedics #privateequity #debtadvisory

🚀 Strategic Growth Through Innovation: Recent Acquisition in Soft Tissue Fixation 🚀 In an exciting move that highlights a major player’s commitment to innovation and comprehensive healthcare solutions, a leading medical technology company has announced its acquisition of a pioneer in soft tissue fixation technology. This acquisition will significantly enhance the company's offerings in the foot, ankle, and sports medicine segments, providing advanced solutions for ligament and tendon reconstruction. As we continue to see rapid advancements in medical technology, such strategic acquisitions are crucial for maintaining leadership in the industry. This move underscores the importance of innovative solutions in improving patient outcomes and reflects a dedication to quality and integrity in healthcare. 🔍 Let's Connect and Innovate! 🔍 I invite you to join the conversation on how strategic acquisitions and innovative technologies are transforming healthcare. How do you see these developments impacting the future of medical treatments? Share your thoughts and let’s explore new frontiers together! #HealthcareInnovation #MedicalTechnology #BusinessGrowth #Leadership https://lnkd.in/e2E4tWKa

Learn about how Ortho-tag’s nanosensors can enhance pH monitoring around orthopaedic implants to reduce the incidence of Periprosthetic Joint Infection (PJI). This article explains how harnessing the power of this breakthrough technology will advance diagnostics, improve patient outcomes, and reduce healthcare costs. Join us on our journey at www.orthotag.com or contact us at info@orthotag.com to learn more about our system and how to invest. #pHsensing #healthcare  #medicaldevice#earlydetection #diseasemanagement #startup #venturecapital #funding#investors

The first-quarter financial results for 2024 are in, and the orthopaedic industry is showing promising growth across key players. Let's delve into the numbers:   Stryker noted total sales of $5.2 billion, marking a 9.7% increase. Within its orthopaedics portfolio, the company achieved $2.2 billion in sales, reflecting a 7.5% uptick. Their individual segments, including the hips, knees, and spine, have all shown positive growth trajectories. These figures suggest that the MedTech giant continues to demonstrate its market resilience.   Zimmer Biomet reports $1.9 billion in total sales, a 3.2% increase, indicating steady progress. Notably, their orthopaedic sales witnessed growth, with knees being a standout performer. The company's diverse portfolio, spanning sports medicine, extremities, trauma, and more, also contributed to its overall upward trend.   Johnson & Johnson maintains its dominant position, boasting a total sales figure of $21.4 billion, a 2.3% increase, reaffirming the company's stature as a cornerstone of the healthcare sector. Their orthopaedic division saw a commendable 4.3% increase, amounting to $2.3 billion in sales. Significant increases in hip and knee sales highlight the company's market prowess.   These figures underscore the resilience and adaptability of the orthopaedic sector, even amidst a dynamic economic landscape. As the industry continues to evolve, these results serve as a testament to the enduring demand for innovative orthopaedic solutions. Looking ahead, stakeholders can anticipate further advancements and opportunities within this vital healthcare sphere.   https://lnkd.in/g6T5r6SU #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #MedDeviceNews #HealthcareNews #MedTechTrends